Home
>
National Drug Code (NDC)
>
Univasc
Univasc - 0091-3707-01 - (moexipril hydrochloride)
Drug Information of Univasc
| Product NDC: | 0091-3707 |
| Proprietary Name: | Univasc |
| Non Proprietary Name: | moexipril hydrochloride |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; moexipril hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Univasc
| Product NDC: | 0091-3707 |
| Labeler Name: | UCB, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020312 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950715 |
Package Information of Univasc
| Package NDC: | 0091-3707-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0091-3707-01) |
NDC Information of Univasc
| NDC Code | 0091-3707-01 |
| Proprietary Name | Univasc |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0091-3707-01) |
| Product NDC | 0091-3707 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | moexipril hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19950715 |
| Marketing Category Name | NDA |
| Labeler Name | UCB, Inc. |
| Substance Name | MOEXIPRIL HYDROCHLORIDE |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
